LabCycle

Executive Summary

LabCycle is a UK-based synthetic biology startup pioneering sustainable biomanufacturing by engineering microbial strains and fermentation processes to produce high-value chemicals, materials, and ingredients from renewable feedstocks. Founded in 2020 and currently in preclinical stage, the company aims to displace petrochemical-derived products with affordable, scalable bio-based alternatives. With a focus on industrial biotechnology and materials science, LabCycle leverages synthetic biology tools to optimize metabolic pathways, enabling cost-effective production of specialty chemicals and advanced materials. The company's platform targets markets such as bioplastics, cosmetics, and industrial intermediates, addressing growing demand for green chemistry solutions. Headquartered in Bath, UK, LabCycle operates with a lean team of under 50 employees and is positioned to capitalize on global regulatory tailwinds and corporate net-zero commitments.

Upcoming Catalysts (preview)

• Q3 2026Series A Funding Round Close70% success
• Q4 2026Strategic Partnership for Feedstock Supply55% success
• Q1 2027Proof-of-Concept Production Milestone for Lead Compound60% success